Background: The increased renal stone size affects the stone clearance rate and the need for nephrostomy in (Percutaneous nephrolithotomy) PCNL. Also, complete stone clearance of bulky renal calculi causes blood loss during PCNL, resulting in hemoglobin drop and sometimes requiring transfusion. This is a frequently encountered phenomenon and is quite problematic for urologists and patients. This study aimed to determine the rate of stone clearance and nephrostomy needed in Mini-PCNL over Conventional PCNL. Methodology: A comparative study was conducted at the urology department of PIMS, Islamabad. A total of eighty (n=80) adult patients of either gender between ages 18-65 years were enrolled. Subjects enrolled had radiographic evidence of renal stones of > 1cm. Group A patients underwent conventional PCNL procedures, and Group B patients underwent Mini PNCL. The rates of stone clearance nephrostomy needed were compared between the two study groups. Results: The mean age of study participants in group A was (33.7 ± 12.1) and in group B (36.5 ± 11.1). The mean sizes of the stone were 2.4 cm and 2.7 cm in groups A and B, respectively. X-rays were used to assess the stone clearance rate on the first operative day in both study groups. Stones were cleared in group-A at 87.5% (n=35) and in group B at 82.5% (n=33). Nephrostomy was needed in group A at 50.0% (n=20) and in group B at 47.5% (n=19). Conclusion: The stone clearance rate and the need for a nephrostomy tube were nearly similar in both intervention groups.
Background: Lithotripsy procedures, especially, Ureterorenoscopy is considered instrumental in treating ureteral stones effectively. In endourological surgery, a pigtail ureteric stent is a widely used method to resolve or prevent ureteral obstruction, promote healing, and reduce the incidence of ureteral strictures. The current study aimed to compare the efficacy of Tamsulosin with Solifenacin and Tamsulosin alone in double-J stents associated with lower urinary tract symptoms using IPS-Score. Methodology: This study was conducted at the Urology Department, Institute of Kidney Diseases (IKD) Peshawar, Pakistan, from Aug 30, 2018, to Feb 28, 2019. Patients with DJ stents were randomly assigned to two groups (Group A & Group B). Group A received Tab Tamsulosin and Solifenacin, while Group B received Tab Tamsulosin alone; the IPS score was calculated at baseline and after 14 days. Results: A total of 100 subjects undergoing unilateral DJ ureteral stenting participated in this study. The post-treatment IPSS Irritative score suggested that Group A has an average IPS score of 4.38+1.77, while in Group B, 6.4+1.55, which was significant with a p-value of 0.000. Conclusion: Post-treatment average IPSS Irritative score of Tamsulosin and Solifenacin combination was less than Tamsulosin alone in patients with unilateral DJ stent.
Background: Transurethral resection of the prostate gland (TURP) is considered a gold standard in Benign Prostatic Hypertrophy. This study aimed to determine the effectiveness of early catheter removals at 48 hours after TURP in patients with mild to moderate enlargement of the prostate. Methodology: A single interventional study was conducted on 79 male subjects with mild to moderate prostate enlargement, and moderate to severe lower urinary tract symptoms. The outcome was measured six hours after trial without a catheter. Results: The mean age of participants was 64.9 ± 7.8 years, and the mean size of the prostate was 54.8 ± 5.9 gm. The frequency of procedural success was 91% (72) and patients with age < 60 years, 24(96%) had procedural success compared to 48(88.9%) age ≥ 60 years. Conclusion: Early catheter removal trial was found successful in most of the study participants at 48 hours after TURP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.